Eating Disorders

Research Update

Lisdexamfetamine for BED: How Effective Over the Long Term?

Topics: Eating Disorders | Research Updates

Review of: Hudson JI et al, JAMA Psychiatry 2017;74(9):903–910. Lisdexamfetamine (Vyvanse) is an extended release amphetamine-based stimulant that is approved for both ADHD and binge eating disorder (BED). To refresh your memory, BED is defined as recurrent episodes (at least once a week over 3 months) of binge eating without compensatory weight lo

Read More
Research Update

Parent-Focused Therapy Outperforms Conjoint Therapy for Anorexia

Topics: Child Psychiatry | Eating Disorders | Research Updates

Read More
Article

Taking Back Control in Binge Eating Disorder

Topics: Child Psychiatry | Eating Disorders | Free Articles

Confined to the appendix in previous editions of the Diagnostic and Statistical Manual (DSM), binge eating disorder (BED) took a leap into the spotlight with its inclusion as an official diagnosis in 2013’s DSM-5. It is one of the more controversial of DSM-5 disorders, with some claiming that BED inappropriately turns overeating and obesity into a psy

Read More
Expert Q&A

Eating Disorders: Assessment and Treatment

Topics: Child Psychiatry | Eating Disorders

Read More
Article

Binge Eating Disorder: Should You Use Vyvanse?

Topics: Eating Disorders | Practice Tools and Tips | Psychopharmacology Tips | Psychotherapy

In January of this year, the FDA approved the stimulant lisdexamfetamine (Vyvanse) as the first drug with an indication for binge eating disorder (BED). Patients are hearing the buzz and may be asking you to prescribe it, but you may have some questions first. Is BED different from extreme overeating which plagues so many Americans? Is this just a stimu

Read More
News of Note

FDA Approves Vyvanse to Treat Binge-Eating Disorder

Topics: Eating Disorders | News of Note

Read More

How Effective is CBT in Treating Anorexia?